89 related articles for article (PubMed ID: 9634724)
1. [Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
Dotsenko VL; Demidova TIu; Neshkova EA; Ametov AS; Iarovaia GA
Vopr Med Khim; 1998; 44(2):203-12. PubMed ID: 9634724
[TBL] [Abstract][Full Text] [Related]
2. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
[TBL] [Abstract][Full Text] [Related]
3. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.
Henriksen EJ; Jacob S
J Cell Physiol; 2003 Jul; 196(1):171-9. PubMed ID: 12767053
[TBL] [Abstract][Full Text] [Related]
4. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy.
Ustündağ B; Canatan H; Cinkilinç N; Halifeoğlu I; Bahçecioğlu IH
Cell Biochem Funct; 2000 Mar; 18(1):23-8. PubMed ID: 10686580
[TBL] [Abstract][Full Text] [Related]
6. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
Fliser D; Rett K; Hübinger A; Ritz E
Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
[TBL] [Abstract][Full Text] [Related]
7. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
Janczak-Bazan A
Ann Acad Med Stetin; 2006; 52(1):51-61; discussion 61-2. PubMed ID: 17131847
[TBL] [Abstract][Full Text] [Related]
8. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
9. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
[TBL] [Abstract][Full Text] [Related]
10. The kallikrein/kinin system in the pathogenesis of hypertension in diabetes mellitus.
Wicklmayr M; Rett K; Baldermann H; Dietze G
Diabete Metab; 1989; 15(5 Pt 2):306-10. PubMed ID: 2693148
[TBL] [Abstract][Full Text] [Related]
11. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
12. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
Bak JF; Gerdes LU; Sørensen NS; Pedersen O
Am J Med; 1992 Apr; 92(4B):69S-72S. PubMed ID: 1580283
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of ACE inhibitors.
Berne C
J Intern Med Suppl; 1991; 735():119-25. PubMed ID: 2043220
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
15. [Effect of brerlipril in patients with non-insulin dependent diabetes mellitus and mild or moderate arterial hypertension as indicated by 24-h blood pressure monitoring].
Ametov AS; Gubina EV; Nikolaev OG
Ter Arkh; 1999; 71(8):17-20. PubMed ID: 10515028
[TBL] [Abstract][Full Text] [Related]
16. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
17. [Effects of perindopril on hypertension, serum angiotensin-I-converting enzyme activity and urine level of N-acetyl-beta-D-glucosaminidase].
Wang Z; Li Y; Zhou Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):233-6. PubMed ID: 9868122
[TBL] [Abstract][Full Text] [Related]
18. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
19. [24-hour arterial hypertension profile and heart rhythm variability in patients with arterial hypertension and NIDDM].
Borovkov NN; Sidorova NV
Klin Med (Mosk); 2002; 80(7):19-21. PubMed ID: 12181808
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.
Dietze GJ; Henriksen EJ
J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):75-88. PubMed ID: 18584583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
